Member Info for maestro1

“Our assessment of the assay performance was very positive. A significant advantage of the Genedrive® 96
SARS-CoV-2 Kit is that the reagents are freeze dried in the plate. This allows for room temperature storage. In
addition technical staff do not have to thaw and prepare the reagents, saving time. We will continue our
collaboration with Genedrive and we are confident that we will be able to adopt this in our lab to provide
sound results with significantly improved throughput.” Professor S. Young

So they want to use this gdr test in labs, its not if but when. Rerate is coming here...

Clark

They can sell in usa without eua. Beckman are gdr distributors in europe also.

Guy

Not having the eua limits sales in usa it doesnt stop sales, gdr can still sell over their.

Lets see what beckman pulls out of the hat, going for the big contracts take time remember other competitors will also be fighting for those contracts.

Tides turned on gdr. Imho

Ppl seem to forget (myself included) that beckman have significant reach in usa, for all we know potential customers may have requested independent verification of the product before purchase, considering fda havent issued eua yet. The case study from new mexico fits that..

Beckman are not here to sell 500k test, they will be looking to sell in the millions.

Guy you might be right but sales will come and over time the orders will increase in india.

At the moment analyst claim 2m ppl are getting infected per day, this is a massive amount. Its going to take along time for normality in india considering population is 1.3bn.

Beckman are getting labs to certify the product by testing it, this data will be key for potential customers without eua.

Its coming together now.

Imho

Guy

I thought they wouldnt pull off the indian approval but they managed to get it passed and validated. Im confident sales will come from their very soon.

Gdr imho put all their chips in usa last year hence they didnt get meaningful sales anywhere else, this was a mistake. I think eua approval is very close now. Gdr pcr test is unique product and with variants changing alot pcr tests will be needed for along time around the world. With these test being able to store in room temperature this will be very appealing for labs.

Later on a takeover is still possible.

Jay

Sales are coming in india, selling one test for around £9 quid to divoc, it will work. Expect to hear something soon.

With regards to Usa, these are freeze dried beads, its different to other tests because fda hasnt approved it companies are hesitant, but tests to see reliability of beads in laboratories will increase confidence, ie successful case studies.

Tide is changing here and eventually fda will test the product.

No it isnt but gdr are in the natuonal framework agreement with dhsc can see them getting it for aihl 100%.

Imho

https://www.genedrive.com/assays/rnr1-product.php

Grimshady

No bang in the head, divoc have been desperate to use gdr test in india for quite some time but regulatory approval was delayed. Now icmr are allowing ce marked products into india but gdr actually got full approval from icmr after they tested the product. This is material in my view.

Prior i believed india put cap on test at £10 and this was uneconomical for gdr but this isnt the case i was wrong, western companies are currently selling tests for around £25-£35. So another positive.

I can see some gdr tests being sold in india in near term.

The case study in new mexico is another positive as its showing the industry the reliability and safety of gdr test with limited supply of reagents.

Sometimes this year dhsc will be purchasing the aihl product. Imho its the only product on the mkt. Videos have been put up on how to use product to prevent baby deafness.

Now i can also see fda approval soon, very soon.
Good luck

Inphobe

Indeed it did, im convinced beckman are doing alot more in the background now.

The first order whether big or small will get the cog rolling, i think gdr are in better spot now especially with approval from India.

Bonkers

Ct scans in uk cost between £450-£600 private. In india its between £15-£35 quid. I said 50 quid.

Look at the difference. Labour is way cheaper in india.
Some western companies are selling pcr tests in india between £25-£35 quid per patient after doing some research. So gdr model can work their.

I am very critical of gdr for not having sales in a pandemic, india pandemic has began now in my view, so im confident they will sell tests in india now. It will take quite some time to settle the virus in india.

In USA the case study from New Mexico was interesting and they want to continue collaborations.

The tide might indeed be changing with gdr, time will tell.

Fact maintain no material sales to date, budd was swimming with sharks in eu.

This indian licenses has indeed made it interesting, india are only doing 1.5m-2m tests per day, that amount is too small for population of 1.3bn. Trend is turning here even without us approval.

India has cheap labour, you need to get out of your western lifestyle.

Ct scan can be done in asian country for £50 here we looking in thousands of pounds.

£25 a test per patient is good. It cost around £4 to make test.

https://www.google.com/amp/s/indianexpress.com/article/india/covid-19-test-prices-rates-india-6896237/lite/

Next few weeks here interesting.

Doozy

Indeed it is but whats happening in india no one expected this, imho over 2m infections per day, gonna take alot to contain.

India have a small percentage of wealthy ppl but population is 1.2bn.

All gdr need is for divoc to buy some tests.

Doozy

Forget the fda thats out of gdr hand they have indian license which they need to concentrate on.

400k infections per day and analyst say real amount 5 x that. Divoc need to put money where their mouth is.

Ggg

Previously they have worded f/o as adavnced this time they state its progressing. So i doubt we hear anything on that regards short term.

Its canada we should be looking at.

Tony end of june.

Why is this falling?

guy they shouldnt be concentrating on fda, its out of their hands what they should be concentrating on is india, they have license their and cases are going over the roof.